Amount Raised
$52 Million
Round Type
Series A
CambridgeBiotechnologyDescription
Strand Therapeutics, a privately held developer of next-generation, programmable mRNA therapeutics for cancer immunotherapy and other diseases, today announced that the company raised $52 million in an oversubscribed Series A financing round syndicated by Redmile Group, BeiGene, Ltd., and Camford Capital, as well as existing investors Playground Global and ANRI. Strand has raised a total of $66 million to date.
Who to call at STRAND THERAPEUTICS INC, and when
A new round usually means STRAND THERAPEUTICS INC is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day STRAND THERAPEUTICS INC raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at STRAND THERAPEUTICS INC, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment STRAND THERAPEUTICS INC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansSTRAND THERAPEUTICS INC raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.